PIK3CA RELATED OVERGROWTH SPECTRUM
Clinical trials for PIK3CA RELATED OVERGROWTH SPECTRUM explained in plain language.
Never miss a new study
Get alerted when new PIK3CA RELATED OVERGROWTH SPECTRUM trials appear
Sign up with your email to follow new studies for PIK3CA RELATED OVERGROWTH SPECTRUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First french registry launched to map mysterious overgrowth conditions
Knowledge-focused CompletedThis study created France's first national registry to better understand rare genetic overgrowth disorders. Researchers collected information from 28 patients with conditions like CLOVES and Klippel-Trenaunay syndromes to learn how common these disorders are and how they affect p…
Matched conditions: PIK3CA RELATED OVERGROWTH SPECTRUM
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
French hospital data reveals scope of rare growth disorders
Knowledge-focused CompletedThis study analyzed French national hospital records from 2015-2022 to understand how common PIK3CA-Related Overgrowth Spectrum (PROS) disorders are in France. Researchers examined data from over 3,600 patients to learn how often these genetic conditions occur, how they're manage…
Matched conditions: PIK3CA RELATED OVERGROWTH SPECTRUM
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC